Background Childhood cancer survivors (CCS) exposed to platinum chemotherapy are at an
increased risk of developing hearing loss and reporting decreased quality of life (QOL). This …

Purpose Auditory complications are potential side effects from childhood cancer treatment.
Yet, limited evidence exists about the impact of auditory complications—particularly tinnitus …

Introduction Hearing loss is a permanent and debilitating side-effect of a range of
interventions commonly used in the treatment of childhood cancers, primarily ototoxic …

Purpose Hearing loss, a complication of cancer treatment, may reduce health-related quality
of life (HRQoL), especially in childhood cancer survivors of central nervous system (CNS) …

Importance Despite advancements in cancer therapy and supportive care, childhood cancer
survivors remain at risk for chronic morbidities associated with disease and treatment, such …

Background Hearing loss is prevalent following ototoxic therapy for childhood cancer.
Associations between hearing loss, self-perceived hearing handicap, and functional …

Background Hearing loss is a potential side effect from childhood cancer treatment. We
described the severity of hearing loss assessed by audiometry in a representative national …

Hearing loss (HL) is common in childhood cancer survivors exposed to platinum
chemotherapy and/or cranial radiation and can severely impact quality of life. Early detection …

Background Hearing loss is a prevalent late effect among cancer survivors. Despite the
significant social costs, there is a noted delay in seeking care and to the authors' knowledge …

Background Hearing loss is a potential late effect after childhood cancer. Questionnaires are
often used to assess hearing in large cohorts of childhood cancer survivors and it is …